Towards best practice in acute stroke care in Ghana: A survey of hospital services

BMC Health Services Research

Volumn 17, Issue 1, 2017, Pages

  Baatiema, Leonard ^a,b   Otim, Michael ^c   Mnatzaganian, George ^d   Aikins, Ama De Graft ^a   Coombes, Judith ^e   Somerset, Shawn ^b  

^a UNIVERSITY OF GHANA   (Ghana)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^c UNIVERSITY OF SHARJAH   (United Arab Emirates)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Evidence based care; Ghana; Health policy; Hospital services; Organised care; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; CLINICAL TRIAL; FEMALE; FIBRINOLYTIC THERAPY; GHANA; HEALTH CARE DELIVERY; HEALTH CARE MANPOWER; HEALTH CARE POLICY; HOSPITAL; HOSPITALIZATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MULTICENTER STUDY; PATIENT REFERRAL; PRACTICE GUIDELINE; QUESTIONNAIRE; STANDARDS; STATISTICS AND NUMERICAL DATA; STROKE; X-RAY COMPUTED TOMOGRAPHY;

ACUTE DISEASE; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; GHANA; HEALTH MANPOWER; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HOSPITALS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; STROKE; SURVEYS AND QUESTIONNAIRES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85011286356     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-017-2061-2     Document Type: Article

References (73)

1. Mensah GA, Norrving B, Feigin VL. The global burden of stroke. Neuroepidemiology. 2015;45(3):143-5.
2. Kaste M, Norrving B. Editorials: from the world stroke day to the world stroke campaign: one in six: act now! Int J Stroke. 2010;5(5):342-3.
3. Daniels ME, Donilon TE, Bollyky TJ. The emerging global health crisis: noncommunicable diseases in low-and middle-income countries. Council on Foreign Relations Independent Task Force Report, vol. 72. 2014.
4. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases, Program on the Global Demography of Aging. 2012.
5. Owolabi MO, Akarolo-Anthony S, Akinyemi R, Arnett D, Gebregziabher M, Jenkins C, et al. The burden of stroke in Africa: a glance at the present and a glimpse into the future. Cardiovasc J Afr. 2015;26(2 suppl 1):S27-38.
6. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355-69.
7. Agyemang C, Attah-Adjepong G, Owusu-Dabo E, De-Graft Aikins A, Addo J, Edusei AK, et al. Stroke in Ashanti region of Ghana. Ghana Med J. 2012;46(2):12-7.
8. Sarfo FS, Akassi J, Awuah D, Adamu S, Nkyi C, Owolabi M, et al. Trends in stroke admission and mortality rates from 1983 to 2013 in central Ghana. J Neurol Sci. 2015;357(1-2):240-5.
9. Sarfo FS, Awuah DO, Nkyi C, Akassi J, Opare-Sem OK, Ovbiagele B. Recent patterns and predictors of neurological mortality among hospitalized patients in Central Ghana. J Neurol Sci. 2016;363:217-24.
10. Sarfo F, Acheampong J, Oparebea E, Akpalu A, Bedu-Addo G. The profile of risk factors and in-patient outcomes of stroke in Kumasi, Ghana. Ghana Med J. 2014;48(3):127-34.
11. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, Ghana Factsheet. Atlanta; 2013. Report No. https://www.cdc.gov/globalhealth/countries/ghana/pdf/ghana-2013.pdf.
12. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-55.
13. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333-41.
14. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182-7.
15. Asplund K. What MONICA told us about stroke. Lancet Neurol. 2005;4(1):64-8.
16. Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725.
17. Dopson S, Fitzgerald L. Knowledge to action?: evidence-based health care in context. Oxford: Oxford University Press; 2005.
18. Sackett DL, Rosenberg W, Gray J, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71-2.
19. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013(9). Art. No.: CD000197. doi: 10.1002/14651858.CD000197.pub3.
20. Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. The Cochrane Library; 2014.
21. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
22. Sandercock PAG, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;(3): Art. No.: CD000029. doi: 10.1002/14651858.CD000029.pub3.
23. Donnan GA, Davis SM, Parsons MW, Ma H, Dewey HM, Howells DW. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol. 2011;7(7):400-9.
24. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215-22.
25. Lindsay P, Furie KL, Davis SM, Donnan GA, Norrving B. World Stroke Organization Global Stroke Services guidelines and action plan. Int J Stroke. 2014;9:4-13.
26. Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol. 2007;6(6):553-61.
27. Langhorne P, de Villiers L, Pandian JD. Applicability of stroke-unit care to low-income and middle-income countries. Lancet Neurol. 2012;11(4):341-8.
28. Berkowitz AL, Mittal MK, McLane HC, Shen GC, Muralidharan R, Lyons JL, et al. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke. 2014;9(3):349-55.
29. Dale S, Levi C, Ward J, Grimshaw JM, Jammali-Blasi A, D'Este C, et al. Barriers and enablers to implementing clinical treatment protocols for fever, hyperglycaemia, and swallowing dysfunction in the quality in acute stroke care (QASC) project-a mixed methods study. Worldviews Evid Based Nurs. 2015;12(1):41-50.
30. Meurer WJ, Majersik JJ, Frederiksen SM, Kade AM, Sandretto AM, Scott PA. Provider perceptions of barriers to the emergency use of tPA for acute ischemic stroke: a qualitative study. BMC Emerg Med. 2011;11(1):5.
31. Williams JM, Jude MR, Levi CR. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: a survey of barriers and enablers. Aust J Rural Health. 2013;21(5):262-7.
32. Leys D, Ringelstein EB, Kaste M, Hacke W. Initiative ECotES. Facilities available in European hospitals treating stroke patients. Stroke. 2007;38(11):2985-91.
33. Network CS. The quality of stroke care in Canada. Ottawa (ON): The Network; 2011.
34. National Stroke Foundation. National Stroke Audit - Acute Services Report. Melbourne: National Stroke Foundation; 2015.
35. Paley L, Kavanagh S, Kavanagh M. Sentinel Stroke National Audit Programme (SSNAP) Clinical Audit January-March 2014 Public Report. 2014.
36. Kengne AP, Anderson CS. The neglected burden of stroke in Sub-Saharan Africa. Int J Stroke. 2006;1(4):180-90.
37. Norrving B, Kissela B. The global burden of stroke and need for a continuum of care. Neurology. 2013;80(3 Suppl 2):S5-S12.
38. Aikins Ad-G. Chronic Non-communicable Diseases in Ghana.: Multidisciplinary Perspectives. Accra: Sub-Saharan Publishers; 2014.
39. Saleh K. World Bank study: a health sector in transition to universal coverage in Ghana. 2012.
40. Rea LM, Parker RA. Designing and conducting survey research: A comprehensive guide. San Francisco: Wiley; 2012.
41. Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. International J Qual Health Care. 2003;15(3):261-6.
42. National Stroke Foundation. National Stroke Audit - acute services organisational survey report. 2013.
43. Purvis T, Cadilhac D, Donnan G, Bernhardt J. Systematic review of process indicators: including early rehabilitation interventions used to measure quality of acute stroke care. Int J Stroke. 2009;4(2):72-80.
44. Wolfe C, McKevitt C, Rudd A. Stroke services: policy and practice across. Europe: Radcliffe Publishing; 2002.
45. Hall RE, Khan F, Bayley MT, Asllani E, Lindsay P, Hill MD, et al. Benchmarks for acute stroke care delivery. International J Qual Health Care. 2013;25(6):710-8.
46. Bowling A. Researhc methods in health: investigating health and health services. 4th ed. England: McGraw-Hill Education (UK); 2014. p. 538.
47. Mosley I, Nicol M, Donnan G, Patrick I, Kerr F, Dewey H. The impact of ambulance practice on acute stroke care. Stroke. 2007;38(10):2765-70.
48. Harbison J, Massey A, Barnett L, Hodge D, Ford GA. Rapid ambulance protocol for acute stroke. Lancet. 1999;353(9168):1935.
49. Durai Pandian J, Padma V, Vijaya P, Sylaja P, Murthy JM. Stroke and thrombolysis in developing countries. Int J Stroke. 2007;2(1):17-26.
50. Ghandehari K. Barriers of Thrombolysis Therapy in Developing Countries. Stroke Res Treat. 2011;2011:686797. doi: 10.4061/2011/686797.
51. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547-53.
52. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RAL, Donnan GA. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit? Cerebrovasc Dis. 2005;20(4):239-44.
53. Saver JL. Time is brain - quantified. Stroke. 2006;37(1):263-6.
54. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke incidence, diagnosis, and pulmonary complications. Stroke. 2005;36(12):2756-63.
55. El Khamlichi A. African neurosurgery: current situation, priorities, and needs. Neurosurgery. 2001;48(6):1344-7.
56. Chin JH. Stroke in sub-Saharan Africa: an urgent call for prevention. Neurology. 2012;78(13):1007-8.
57. Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450(7169):494-6.
58. Goldstein L, Matchar D, Hoff-Lindquist J, Samsa G, Horner R. VA Stroke Study Neurologist care is associated with increased testing but improved outcomes. Neurology. 2003;61(6):792-6.
59. Akinyemi RO, Owolabi MO, Adebayo PB, Akinyemi JO, Otubogun FM, Uvere E, et al. Task-shifting training improves stroke knowledge among Nigerian non-neurologist health workers. J Neurol Sci. 2015;359(1):112-6.
60. World Health Organization. Noncommunicable Diseases Country Profile 2014. Geneva: WHO; 2014.
61. Bosu W. A comprehensive review of the policy and programmatic response to chronic non-communicable disease in Ghana. Ghana Med J. 2013;46(2):69-78.
62. Aikins A-G, Boynton P, Atanga LL. Review developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon. 2010.
63. Ama de-Graft Aikins, Samuel Agyei-Mensah, Charles Agyemang. Chronic Non-communicable Diseases in Ghana. Multidisciplinary Perspectives (Vol. 1). Sub-Saharan Publishers; 2013.
64. Cadilhac D, Lalor E, Pearce D, Levi C, Donnan G. Access to stroke care units in Australian public hospitals: facts and temporal progress. Intern Med J. 2006;36(11):700-4.
65. Rudd A, Hoffman A, Down C, Pearson M, Lowe D. Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission. Age Ageing. 2007;36(3):247-55.
66. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. 2005.
67. Fuster V, Voute J, Hunn M, Smith SC. Low priority of cardiovascular and chronic diseases on the global health agenda a cause for concern. Circulation. 2007;116(17):1966-70.
68. Institute for Health Metrics and Evaluation. Financing Global Health 2015: development assistance steady on the path to new Global Goals. Seattle: Institute for Health Metrics and Evaluation; 2016.
69. Atun R, Jaffar S, Nishtar S, Knaul FM, Barreto ML, Nyirenda M, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet. 2013;381(9867):690-7.
70. Byfield S, Moodie R. Addressing the world's biggest killers: Non-communicable diseases and the international development agenda. 2013.
71. Atuguba RA. The right to health in Ghana: healthcare, human rights, and politics. Oxford: Oxford University Press; 2013.
72. Ghana Health Service. 2014 Annual Report. Accra: GHS; 2015. Available from: https://www.ghanahealthservice.org/downloads/Ghana-Health-Service-2014-Annual-Report.pdf.
73. General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14.